Ignite Creation Date:
2024-05-06 @ 2:36 AM
Last Modification Date:
2024-10-26 @ 11:20 AM
Study NCT ID:
NCT02082691
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2014-03-10
First Post:
2014-03-06
Brief Title:
Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma
Sponsor:
Devalingam Mahalingam
Organization:
The University of Texas Health Science Center at San Antonio
Study Overview
Official Title:
Single Patient IND Continued Administration of G-202 to a Patient With Advanced Hepatocellular Carcinoma Previously Treated With G-202 and Receiving Clinical Benefit
Status:
NO_LONGER_AVAILABLE
Status Verified Date:
2014-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patient with advanced liver cancer cancer that has spread to other parts of the body continues to receive the study drug G-202 even though patient no longer meets the criteria to be a part of the main treatment study Patients cancer responded well to receiving G-202 in the main study and will receive G-202 at the same dose given in the main study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HSC20130391T UTHSCSA IRB | None | None | None |